Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

African Leader pledge support for immunisation
  • USA - English


News provided by

GAVI Alliance

May 08, 2014, 10:50 ET

Share this article

Share toX

Share this article

Share toX

Abuja (PRWEB UK) 8 May 2014 -- African leaders have pledged to prioritise sustainable immunisation programmes as part of continued investment in the healthy futures of children and families in their countries.

The Immunise Africa 2020 leaders‘ declaration, launched in Abuja today during an event hosted by Donald Kaberuka, President of the African Development Bank, recognises the US$ 700 million that African Governments are projected to spend on co-financing vaccines purchased by the GAVI Alliance between 2016 and 2020. This is additional to the billions of dollars African countries already spend on health services.

The declaration text also highlights the strong progress being made on improving the health of people across Africa but calls on the GAVI Alliance and its partners to do more to help continue the decline in child death rates on the continent. President Kaberuka was joined at the event by President John Dramani Mahama of the Republic of Ghana, President Macky Sall of the Republic of Senegal and President Jakaya Kikwete of the United Republic of Tanzania who all offered their endorsement.

“Immunisation is one of the most important investments we are making in our children and in their future,” said President Mahama. “We are committed to ensuring that vaccine programmes in Ghana will be sustainable, so that our children are fully protected from potentially fatal diseases.”

President Kikwete further added that "immunisation represents one of the smartest investments we can make in the health of our citizens and the future of our nations.”

“As leaders of this dynamic continent, we will ensure that our children have access to the best, most sustainable technologies to provide them with the best possible start in life,” added President Sall.

“The investments countries are making in vaccines today will reap enormous benefits in the short and the near term,” said President Kaberuka. “By committing to immunisation, African leaders are taking a bold step towards securing their countries’ prosperity and economic security.”

African leaders’ support for the Immunise Africa 2020 declaration comes less than two weeks before a major meeting in Brussels where the GAVI Alliance will present to its partners the funding requirements needed during the five-year period from the beginning of 2016 to build upon the gains already achieved against the biggest killers of children.

Donor funding will be crucial and catalytic to securing GAVI-supported programmes through to 2020 but implementing countries are also playing their part through the Alliance’s co-financing and graduation policies.

Under the co-financing policy, countries make a financial payment – starting at $0.20 per dose for the poorest countries – towards the costs of vaccines supplied by the GAVI Alliance. Between 2011 and 2015 African countries will make US$ 254 million in co-financing payments. Between 2016 and 2020 the figures is projected to almost treble to an estimated US$ 700 million.

The GAVI Alliance’s graduation policy also supports African countries towards self-sufficient immunisation programmes. When a country’s gross national income (GNI) per capita exceeds a threshold, currently US$ 1,570, it enters the graduation phase. This means that GAVI Alliance vaccine funding diminishes over a period of five years until the countries’ vaccine programmes have become fully self-sufficient.

The commitments – both political and financial – from implementing countries are a vital part of the success of the GAVI Alliance. Donor funding and work to reduce vaccine prices are the other two key pillars that have enabled the global public-private partnership to fund the immunisation of 440 million children since 2000, saving approximately six million lives.

# # #

Notes to editors:

The Immunise Africa 2020 leaders’ declaration was launched at the World Economic Forum on Africa in Abuja, Nigeria. For photographs of the launch event please see the World Economic Forum’s photostream: https://www.flickr.com/photos/worldeconomicforum/collections/72157644028871490/.

To view the Immunise Africa 2020 leaders’ declaration, please use the following links:
http://www.gavialliance.org/immunise-africa-2020 (English)
http://www.gavialliance.org/fr/2020-afrique-vaccine (French)

About the GAVI Alliance
The GAVI Alliance is a public-private partnership committed to saving children’s lives and protecting people’s health by increasing access to immunisation in poor countries. The Alliance brings together developing country and donor governments, the World Health Organization, UNICEF, the World Bank, the vaccine industry, technical agencies, civil society, the Bill & Melinda Gates Foundation and other private sector partners. GAVI uses innovative finance mechanisms, including co-financing by recipient countries, to secure sustainable funding and adequate supply of quality vaccines. Since 2000, GAVI has contributed to the immunisation of an additional 440 million children and the prevention of approximately 6 million future deaths. Learn more at http://www.gavialliance.org and connect with us on Facebook and Twitter.

The GAVI Alliance is funded by governments (Australia, Canada, Denmark, France, Germany, India, Ireland, Italy, Japan, Luxembourg, the Netherlands, Norway, Republic of Korea, Russia, South Africa, Spain, Sweden, United Kingdom, and United States), the European Commission, the OPEC Fund for International Development (OFID), the Bill & Melinda Gates Foundation, and His Highness Sheikh Mohamed bin Zayed Al Nahyan, as well as private and corporate partners (Absolute Return for Kids, Anglo American plc., the A&A Foundation, The Children’s Investment Fund Foundation, Comic Relief, the ELMA Vaccines and Immunization Foundation, JP Morgan, “la Caixa” Foundation, LDS Charities, Lions Club International Foundation, and Vodafone).

To access broadcast-quality footage from the GAVI library, please visit: http://www.gavi-video.org/content/index.asp

Media interest
Rob Kelly
GAVI Alliance
Tel: +41 22 909 2978
Mob: +41 79 745 2031
Email: rkelly(at)gavialliance(dot)org

Rob Kelly, GAVI Alliance, +41 229092978, [email protected]

Modal title

Leaders' Declaration
View PDF
Leaders' Declaration
Déclaration des dirigeants
View PDF
Déclaration des dirigeants
Les dirigeants Africains affirment leur soutien en faveur de la vaccinations
View PDF
Les dirigeants Africains affirment leur soutien en faveur de la vaccinations
Leaders' Declaration Déclaration des dirigeants Les dirigeants Africains affirment leur soutien en faveur de la vaccinations

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.